|
Sign In to gain access to subscriptions and/or personal tools.
|
Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro
Philip HeiSer
Department of Psychiatry and Psychotherapy, Philipps-University of Marburg, Marburg, Germany, heiser{at}mailer.uni-marburg.de
Frank Enning
Department of Psychiatry and Psychotherapy, Philipps-University of Marburg, Marburg, Germany
Jürgen-Christian Krieg
Krieg Department of Psychiatry and Psychotherapy, Philipps-University of Marburg, Marburg, Germany
Helmut Vedder
Department of Psychiatry and Psychotherapy, Philipps-University of Marburg, Marburg, Germany
Cytotoxic effects on neuronal as well as on immune cells have been reported for both typical and atypical antipsychotic drugs. We evaluated the effects of different concentrations of a typical (haloperidol) and two atypical (clozapine, olanzapine) antipsychotics on the survival of human neuronal (SH-SY5Y cells) and immune cells (U937 cells) by determining the metabolic activity after 24 h of incubation by the modified tetrazolium method. The dopaminergic neuroblastoma SH-SY5Y and the lymphoma U-937 cell line are well established models for in vitro investigations. To further elucidate possible mechanisms of action we also determined the ATP content in the cultured cells.
After experimental treatment, significant effects were detected by Kruskal Wallis test for all treatment conditions. Post-hoc tests (Dunn's method) showed that haloperidol and clozapine at the two highest concentrations (25 and 50 µg/ml) caused a significant decrease of metabolic activity in both cell systems, which was also detectable after treatment with clozapine at a concentration of 12.5 µg/ml in U937 cells. In contrast, olanzapine induced a significant increase in metabolic activity of SH-SY5Y cells at all concentrations except for the concentration of 3.1 µg/ml, whereas the metabolic activity in U937 cells was increased at concentrations of 1.6 and 6.25 µg/ml. For the determination of ATP content, the LD50 values of the metabolic activity were used, except for olanzapine for which no distinct LD50 value was available. Significant changes were detected for all treatments and post-hoc tests revealed that haloperidol caused a significant decrease compared to the control condition in both cell systems. These findings suggest that antipsychotic substances of different classes exert differential metabolic effects in both neuronal and immune cell systems.
Key Words: antipsychotic toxicity metabolic activity ATP cell
References
- Ardizzone T.D., Bradley R.J., Freeman A.M. 3rd, Dwyer, DS (2001) Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine. Brain Res 923: 82—90[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Behl C. ( 1999) Vitamin E and other antioxidants in neuroprotection. Int J Vitam Nutr Res 69: 213—219[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Behl C., Rupprecht R., Skutella T., Holsboer F. (1995) Haloperidol-induced cell death—mechanism and protection with vitamin E in vitro. Neuroreport 7: 360—364[Web of Science][Medline]
[Order article via Infotrieve]
- Carpenter W.T. Jr, Buchanan R.W. (1994) Schizophrenia. N Engl J Med 330: 681—690[Free Full Text]
- Chiarugi A. (2005) "Simple but not simpler": toward a unified picture of energy requirements in cell death. FASEB J 19: 1783—1788[Abstract/Free Full Text]
- Deicken R.F., Calabrese G., Merrin E.L., Fein G., Weiner M.W. (1995) Basal ganglia phosphorous metabolism in chronic schizophrenia. Am J Psychiatry 152: 126—129[Abstract/Free Full Text]
- Dwyer D.S., Pinkofsky H.B., Liu Y., Bradley R.J. (1999) Antipsychotic drugs affect glucose uptake and the expression of glucose transporters in PC12 cells. Prog Neuropsychopharmacol Biol Psychiatry 23: 69—80[CrossRef][Medline]
[Order article via Infotrieve]
- Dwyer D.S., Lu XH, Bradley R.J. (2003) Cytotoxicity of conventional and atypical antipsychotic drugs in relation to glucose metabolism. Brain Res 971: 31—39[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Fujimoto T., Nakano T., Takano T., Hokazono Y., Asakura T., Tsuji T. (1992) Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging. Acta Psychiatr Scand 86: 455—462.[Web of Science][Medline]
[Order article via Infotrieve]
- Fukuzako H. (2001) Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy. World J Biol Psychiatry 2: 70—82
- Galili-Mosberg R., Gil-Ad I., Weizman A., Melamed E., Offen D. (2000) Haloperidol-induced neurotoxicity—possible implications for tardive dyskinesia. J Neural Transm 107: 479—490[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Gardner I., Zahid N., MacCrimmon D., Uetrecht JP (1998) A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes. Mol Pharmacol 53: 991—998[Abstract/Free Full Text]
- Harris P., Ralph P. (1985) Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J Leukoc Biol 37: 407—422[Abstract]
- Heiser P., Singh S., Krieg J.C., Vedder H. (2006) Effects of different antipsychotics and the antidepressant mirtazapine on glucose transporter mRNA levels in human blood cells. J Psychiatr Res 40: 374—379[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Iqbal M.M., Rahman A., Husain Z., Mahmud S.Z., Ryan W.G., Feldman J.M. (2003) Clozapine: a clinical review of adverse effects and management. Ann Clin Psychiatry 15: 33—48[CrossRef][Medline]
[Order article via Infotrieve]
- Klöcking R., Schacke M., Wutzler P. (1995) Primärscreening antiherpetischer Verbindungen mit EZ4U. Chemotherapie J 4: 141—147
- Koizumi S., Ikeda M., Nakazawa K., Inoue K., Ito K., Inoue K. (1995) Inhibition by haloperidol of adenosine 5'-triphosphate-evoked responses in rat pheochromocytoma cells. Biochem Biophys Res Commun 210: 624—630[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kornhuber J., Schultz A., Wiltfang J., Meineke I., Gleiter C.H., Zochling R., Boissl K.W., Leblhuber F., Riederer P. (1999) Persistence of haloperidol in human brain tissue. Am J Psychiatry 156: 885—890[Abstract/Free Full Text]
- Kowalski J., Blada P., Kucia K., Madej A., Herman ZS (2001) Neuroleptics normalize increased release of interleukin- 1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia. Schizophr Res 50: 169—175[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Leykin I., Mayer R., Shinitzky M. (1997) Short and long-term immunosuppressive effects of clozapine and haloperidol. Immunopharmacology 37: 75—86[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Llorca P.M., Chereau I., Bayle F.J., Lancon C. (2002) Tardive dyskinesias and antipsychotics: a review. Eur Psychiatry 17: 129—138[Web of Science][Medline]
[Order article via Infotrieve]
- Maurer I., Möller H.J. (1997) Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics. Mol Cell Biochem 174: 255—259[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Miller D.D. (2000) Review and management of clozapine side effects. J Clin Psychiatry 61(Suppl 8): 14—17
- Pahlman S., Mamaeva S., Meyerson G., Mattsson ME, Bjelfman C., Ortoft E., Hammerling U. (1990) Human neuroblastoma cells in culture: a model for neuronal cell differentiation and function. Acta Physiol Scand 592(Suppl): 25—37
- Pettegrew J.W., Keshavan MS, Panchalingam K., Strychor S., Kaplan D.B., Tretta M.G., Allen M. (1991) Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch Gen Psychiatry 48: 563—568[Abstract/Free Full Text]
- Pochet S., Garcia-Marcos M., Fernandez M., Marino A., Dehaye J.P. (2003) Regulation by clozapine of calcium handling by rat submandibular acinar cells. Cell Calcium 34: 465—475[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Silver M.A., Yang Z.W., Ganguli R., Nimgaonkar VL (1994) An inhibitory effect of psychoactive drugs on a human neuroblastoma cell line. Biol Psychiatry 35: 824—826[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Skinner TE, O'Donnell J.M., Robitaille P.M., Nasrallah H.A. (1995) 31P MRS study of clozapine vs. haloperidol effects on brain metabolism (abstract). Biol Psychiatry 37: 648
- Skulachev V.P. (2006) Bioenergetic aspects of apoptosis, necrosis and mitoptosis. Apoptosis 11: 473—485[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Suda T., Suzuki Y., Matsui T., Inoue T., Niide O., Yoshimaru T., Suzuki H., Ra C., Ochiai T. (2005) Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner. Br J Dermatol 152: 887—895[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sunderland T., Cohen BM (1987) Blood to brain distribution of neuroleptics. Psychiatry Res 20: 299—305[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Tschen A.C., Rieder M.J., Oyewumi L.K., Freeman D.J. (1999) The cytotoxicity of clozapine metabolites: implications for predicting clozapine-induced agranulocytosis. Clin Pharmacol Ther 65: 526—532[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Tsuneizumi T., Babb S.M., Cohen B.M. (1992) Drug distribution between blood and brain as a determinant of antipsychotic drug effects. Biol Psychiatry 32: 817—824[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Vairetti M., Feletti F., Battaglia A., Pamparana F., Canonico PL, Richelmi P., Berte F. (1999) Haloperidol-induced changes in glutathione and energy metabolism: effect of nicergoline. Eur J Pharmacol 367: 67—72[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Vilner B.J., Bowen W.D. (1993) Sigma receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture. Eur J Pharmacol 244: 199—201
- Volz H.P., Rzanny R., Rossger G., Hubner G., Kreitschmann-Andermahr I., Kaiser W.A., Sauer H. (1997) Decreased energy demanding processes in the frontal lobes of schizophrenics due to neuroleptics? A 31P-magneto-resonance spectroscopic study. Psychiatry Res 76: 123—129[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Volz H.R., Riehemann S., Maurer I., Smesny S., Sommer M., Rzanny R., Holstein W., Czekalla J., Sauer H. (2000) Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31)P chemical shift spectroscopic-imaging study. Biol Psychiatry 47: 954—961[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Yang S.B., Proks P., Ashcroft F.M., Rupnik M. (2004) Inhibition of ATPsensitive potassium channels by haloperidol. Br J Pharmacol 143: 960—967[CrossRef][Web of Science]
This version was published on November
1, 2007
Journal of Psychopharmacology, Vol. 21, No. 8,
851-856 (2007)
DOI: 10.1177/0269881107077221

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|